Can low pregnenolone plus low morning cortisol and low DHEA‑S indicate reduced adrenal steroid output and relate to fatigue?

The synthesis of adrenal hormones relies on a shared biochemical foundation, where the conversion of cholesterol into pregnenolone serves as the rate-limiting step for the entire steroidogenic pathway. When levels of the precursor pregnenolone are low, it naturally restricts the available substrate for downstream production of both cortisol and dehydroepiandrosterone (DHEA).

Clinical and Mechanistic Evidence

The adrenal glands process pregnenolone through divergent enzymatic pathways to meet physiological demands:

• Glucocorticoid Pathway: In the zona fasciculata, pregnenolone is converted into cortisol via a series of enzymatic steps involving CYP17A1 and CYP11B1. This pathway is critical for glucose metabolism and the systemic response to acute stress.
• Androgen Pathway: In the zona reticularis, pregnenolone is converted to DHEA and its sulfated form, DHEA-S. This pathway is heavily dependent on the 17,20-lyase activity of the CYP17A1 enzyme.
• Systemic Output: Research indicates that concurrent low levels of pregnenolone, morning cortisol, and DHEA-S suggest a global reduction in adrenal steroidogenesis. This pattern often reflects a "blunted" hypothalamic-pituitary-adrenal (HPA) axis, where the adrenal glands are either receiving insufficient stimulation from the pituitary gland (ACTH) or have a reduced functional capacity to synthesize hormones.

Impact on Fatigue and Stress Resilience

The relationship between reduced adrenal output and clinical symptoms is well-documented in states of HPA axis dysregulation:

• Fatigue and Recovery: Low morning cortisol—a marker of the "awakening response"—is associated with persistent fatigue and lethargy. Studies in aging populations and those with chronic exhaustion show that a flattened cortisol curve is a frequent biomarker of impaired recovery from daily stressors.
• Resilience and Aging: For a 61-year-old female, the decline in DHEA-S (adrenopause) is a natural occurrence; however, when combined with low cortisol and low pregnenolone, it characterizes a state of reduced physiological resilience. DHEA-S acts as an important antagonist to the potentially catabolic effects of cortisol, and its deficiency is linked to reduced physical performance and lower stress tolerance.

Bottom line

The claim is supported by biochemical and clinical evidence. A profile of low pregnenolone, cortisol, and DHEA-S represents a coordinated reduction in adrenal output that mechanistically correlates with fatigue and a diminished capacity to maintain homeostasis under stress.